Viewing Study NCT05919693


Ignite Creation Date: 2025-12-25 @ 1:19 AM
Ignite Modification Date: 2026-02-01 @ 5:04 AM
Study NCT ID: NCT05919693
Status: COMPLETED
Last Update Posted: 2025-11-20
First Post: 2023-06-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A 2-part Study Consisting of Multiple Ascending Dose (MAD) Safety Study, and a Dose-finding Masked Study to Assess the Safety and Efficacy of Intravitreal (IVT) EYE103 in Patients With Diabetic Macular Edema (DME) or Neovascular Age-related Macular Degeneration (NVAMD)
Sponsor: EyeBiotech Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neovascular Age-related Macular Degeneration (NVAMD) View
None Diabetic Macular Edema (DME) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Neovascular Age-related Macular Degeneration (NVAMD) View
None Diabetic Macular Edema (DME) View
None Age-related Macular Degeneration (AMD) View